Transplantation · 20 Nov 2026
Anti-HLA Alloantibody Responses in Living Donor Uterus Transplantation: A Single-center Case Series
Florian Regnath, Markus W. Löffler, Sandra Hammer, Silvio Nadalin, Markus Quante, Stefan G. Tullius, Friederike Martin, Daniel Fürst, Martina Guthoff, Nils Heyne, Katharina Rall, Sara Y. Brucker, Tamam Bakchoul, Karina Althaus
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background. Until 1 decade ago, absolute uterine infertility invariably prevented women from bearing their own biological child. A major causative factor is Mayer-Rokitansky-Küster-Hauser syndrome. However, uterus transplantation (UTx) has recently emerged as a successful treatment strategy, with >70 children being born to UTx recipients. This clinical situation represents a unique immunological scenario—namely the combined sensitization risk from solid organ transplantation and exposure to paternal alloantigens of the fetus. Methods. Given the rarity of such cases, we assessed HLA sensitization in this context using a microbead-based assay (Luminex) with HLA screening as well as single-antigen beads in 7 UTx patients. Results. We observed broad, strong IgG alloimmune responses in 3 UTx recipients, directed against both donor and paternal alloantigens. These responses primarily emerged and amplified after graft hysterectomy and withdrawal of immunosuppression, while intermittently also being evidenced before hysterectomy in 1 case. This contrasts with 4 women with transplants remaining in situ and on immunosuppressive treatment, who lack sensitization signs so far. Conclusions. These scarce preliminary data already suggest a relevant risk of broad sensitization in this unusual setting. UTx may therefore (1) represent a unique model for studying HLA sensitization under combined physiological and nonphysiological conditions, (2) warrant informing recipients about the risk of HLA alloimmunization, and (3) require further investigation to understand the implications and long-term consequences, demanding the generation of larger datasets.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (30)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 10 more references
A free account opens the rest of the citing papers and references on every paper’s page.